$68.98
S4 + LGD 4033 tablets is offered in 2 variants: 40mg per tablet for 27 tablets, totaling 1080mg and 40mg per tablet for 54 tablets, totaling 2160mg.
S4 is a potential treatment for conditions relating to muscle wasting, osteoporosis and benign prostatic hyperplasia. LGD is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis.
S4 | |
CAS Number | 19269-85-3 |
Molar Mass | 128.3 g/mol-1 |
Chemical Formula | S4 |
IUPAC Name | Tetrathietane |
LGD-4033 | |
CAS Number | 1165910-22-4 |
Molar Mass | 338.253 g·mol−1 |
Chemical Formula | C14H12F6N2O |
IUPAC Name | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile |